Australian Biomedical Company Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1995-12-07 and was issued with the 072096390 ACN. Its Australian Business Number is 31072096390. Since 2000-08-14, the company is headquartered in VIC, post code 3143. Australian Biomedical Company Pty Ltd was registered for the GST on 2001-04-01. Australian Biomedical Company Pty Ltd has been using the Australian Biomedical Company Pty Ltd trading name since 2000-08-14 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2001-04-01.
| Status | From | To |
|---|---|---|
| Active | 1st July 2000 | current |
| Name | From | To |
|---|---|---|
| Australian Biomedical Company Pty. Ltd. | 5th October 2000 | current |
| Australian Biomedical Company Pty Ltd | 1st July 2000 | 5th October 2000 |
| Name | From | To |
|---|---|---|
| Australian Biomedical Company Pty Ltd | 14th August 2000 | current |
| Location | From | To |
|---|---|---|
| VIC 3143 | 14th August 2000 | current |
| Status | From | To |
|---|---|---|
| Registered | 1st April 2001 | current |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 3/04 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 3 - drugs for disorders of the metabolism (of the blood or the extracellular fluid a61p0007000000) |
| Subgroup code: | 4 - anorexiants; antiobesity agents |
IP Australia process information:
| Expiry date: | 12th August 2022 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61K 31/7008 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 31 - medicinal preparations containing organic active ingredients |
| Subgroup code: | 7008 - compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. d-galactosamine, ranimustine |
IP Australia process information:
| Expiry date: | 2nd July 2030 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | A61K 35/74 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 35 - medicinal preparations containing materials or reaction products thereof with undetermined constitution |
| Subgroup code: | 74 - bacteria (therapeutic use of a bacterial protein a61k0038000000) |
IP Australia process information:
| Expiry date: | 12th August 2022 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.